Human immunodeficiency virus type 1 (HIV-1)pre-mRNA splicing is regulated in order to maintain pools of unspliced and partially spliced viral RNAs as well as the appropriate levels of multiply spliced mRNAs during virus infection. We have previously described an element in tat exon 2 that negatively regulates splicing at the upstream tat 3 splice site 3 (B. A. Amendt, D. Hesslein, L.-J. Chang, and C. M. Stoltzfus, Mol. Cell. Biol. 14:3960-3970, 1994). In this study, we further defined the element to a 20-nucleotide (nt) region which spans the C-terminal vpr and N-terminal tat coding sequences. By analogy with exon splicing enhancer (ESE) elements, we have termed this element an exon splicing silencer (ESS). We show evidence for another negative cis-acting region within tat-rev exon 3 of HIV-1 RNA that has sequence motifs in common with a 20-nt ESS element in tat exon 2. This sequence is juxtaposed to a purine-rich ESE element to form a bipartite element regulating splicing at the upstream tat-rev 3 splice site. Inhibition of the splicing of substrates containing the ESS element in tat exon 2 occurs at an early stage of spliceosome assembly. The inhibition of splicing mediated by the ESS can be specifically abrogated by the addition of competitor RNA. Our results suggest that HIV-1 RNA splicing is regulated by cellular factors that bind to positive and negative cis elements in tat exon 2 and tat-rev exon 3.Alternative splicing of mRNA precursors plays a critical role in the regulation of gene expression. In metazoan cells, splicing of pre-mRNA is mediated by cis-acting signals which include 5Ј and 3Ј splice sites, branchpoint sequences, and polypyrimidine tracts preceding 3Ј splice sites (for a review, see reference 19). However, the mechanisms by which alternative splice site selection is regulated are not well understood. There are numerous examples of sequences within introns that act to either enhance or inhibit splicing (3,7,10,16,21,25,35,40,43,65). Some of these intron sequences have been shown to bind cellular factors (21,35,40,43). Exon sequences have also been shown to play a role in alternative splicing. Positive-acting exon sequences and purine-rich regions or exon splicing enhancer (ESE) elements have been reported for a number of different cellular and viral genes (4,5,8,23,30,36,50,51,53,56,(58)(59)(60). Some of these positive-acting exon sequences are binding sites for cellular factors (5,23,30,50,58). A family of factors called SR proteins are required for splicing and, in some cases, have been shown to regulate alternative splice site selection in a concentration-dependent manner (14,17,28,33,61). Recent reports have shown that the SR proteins selectively bind to purine-rich splicing elements present in cellular exons (30,49,50). There are also several examples of negative-acting exon splicing elements (2,4,18,45,55). To date, factors interacting with negative-acting exon splicing elements affecting alternative 3Ј splice site usage in metazoan cells have not yet been reported.Human immunodeficie...